Traditional Chinese medicine ointment for superficial vein embolism caused by clinical examination blood sampling and preparation method thereof

A clinical test, superficial vein technology, applied in the direction of pharmaceutical formulations, non-central analgesics, medical preparations of non-active ingredients, etc., can solve adverse reactions, superficial vein thrombosis, and aspirin enteric-coated tablets should not be taken too much, etc. achieve good curative effect

Inactive Publication Date: 2016-07-13
匡建梅
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because blood collection is an invasive operation, adverse symptoms such as superficial vein thrombosis are often caused by the patient's own or the operator's technical level, especially children's blood vessels are delicate, and improper operation during venous blood collection is more lik

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine ointment for superficial vein embolism caused by clinical examination blood sampling and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0049] Copper hammer grass 55-66g, blood disc grass 52-63g, milk pulp root 48-60g, salvia miltiorrhiza 45-56g, sweet potato vine 42-53g, sargassum 39-50g, daughter red root 36-47g, chuanxiong 33-44g, Corydalis 30-41g, lotus hawk's claw 27-38g, cinnamon 24-35g, licorice 21-32g, peony 18-28g, acanthopanax 15-25g, bayberry bark 12-22g, atractylodes 10-19g, holly 7-16g, 5-14g peach kernel, 3-12g scallops, 1-10g borneol.

[0050] The processing steps of the pharmaceutical preparation method of the present invention are:

[0051] (1) Wash and dry the blood plate grass, milk pulp root, sweet potato vine, cleats, daughter red root, eagle claw lotus, and hairy holly, mix them evenly, put them in a container, and add 6 to 8 times the amount to the container of water, heated and boiled for 2 to 3 hours, and the infusion was taken after cooling; 4 to 6 times the amount of ...

Embodiment 2

[0063] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0064] Copper hammer grass 58-63g, blood disc grass 55-60g, milk pulp root 51-57g, salvia miltiorrhiza 48-53g, sweet potato vine 45-50g, sargassum 42-47g, daughter red root 39-44g, chuanxiong 36-41g, Yanhusuo 33~38g, Eagle claw lotus 30~35g, Sichuan cinnamon bark 27~32g, licorice 24~29g, wild peony 21~25g, Acanthopanax 18~22g, bayberry bark 15~19g, atractylodes 13~16g, hair holly 9-13g, 7-12g peach kernel, 5-10g scallops, 3-7g borneol.

[0065] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.

Embodiment 3

[0067] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0068] 60g copper hammer grass, 57g blood disk grass, 54g milk pulp root, 51g salvia miltiorrhiza, 48g sweet potato vine, 45g sarcasm, 42g daughter red root, 39g chuanxiong, 36g yanhusuo, 33g eagle claw lotus, 30g cinnamon bark, 27g licorice, wild Peony 23g, Acanthopanax 20g, bayberry bark 17g, atractylodes 14g, hairy holly 11g, peach kernel 9g, westerus 7g, borneol 5g.

[0069] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.

[0070] clinical information:

[0071]1. Case selection

[0072] 58 cases of superficial venous thrombosis patients diagnosed in our hospital were selected for clinical observation, and the patients were randomly divided into two groups. The treatment group included 29 cases, including 17 males and 12 females, aged 1 to 57 years, with an average age of 34.6 yea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine ointment for superficial vein embolism caused by clinical examination blood sampling and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The effective ingredient of the ointment is prepared from the following raw materials: oxalis corymbosa, salvia cavaleriei, fig roots, salvia miltiorrhiza, ficus tikoua, lindernia angustifolia, berchemia yunnanensis franch, ligusticum wallichii, rhizoma corydalis, saus-surea peguensis, cinnamomum mairei, licorice root, common melastoma herb, radix acanthopanacis semticosi, hairy waxmyrtle bark, rhizoma atractylodis, ilex pubescens, peach kernels, herba siegesbeckiae and borneol. The traditional Chinese medicine ointment is prepared from medicinal materials in accordance with the principle of monarch, minister, assistant and guide, is applied according to the pathogenesis, has the effects of clearing heat, inducing diuresis, promoting circulation of qi and blood, promoting blood circulation to remove stasis, promoting blood circulation to remove meridian obstruction, inhibiting bacteria, diminishing inflammation, diminishing swelling and relieving pain, and has a good absorption effect, a remarkable curative effect, no toxic or side effect and no clinical adverse response. Clinical application verifies that the traditional Chinese medicine ointment has a relatively high cure rate on superficial vein embolism caused by blood sampling.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine ointment for clinical testing of superficial vein thrombosis caused by blood collection and a preparation method. Background technique [0002] Blood is composed of two parts, plasma and blood cells. In the body, it is closely connected with various tissues and organs of the whole body through the blood circulatory system, exchanges materials with various tissues of the body, and participates in various activities of the body. It plays a vital role in maintaining the balance of the internal and external environment of the body. Under pathological conditions, besides directly affecting blood, diseases of the blood system can also affect tissues and organs throughout the body, and lesions of tissues and organs can also directly or indirectly cause blood changes. Therefore, blood test is one of the most important indicators for judging var...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/80A61K9/06A61P7/02A61P29/00A61K31/045
CPCA61K36/80A61K9/0014A61K9/06A61K31/045A61K36/185A61K36/236A61K36/254A61K36/28A61K36/284A61K36/484A61K36/53A61K36/537A61K36/54A61K36/60A61K36/66A61K36/72A61K36/736A61K47/46A61K2236/331A61K2300/00
Inventor 匡建梅徐全民徐睿
Owner 匡建梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap